Functional recovery of islet β cells in human type 2 diabetes: Transcriptome signatures unveil therapeutic approaches.
AuteursSuleiman M, Sawatani T, Tesi M, Yi X, Papadopoulou T, Rufer C, Lytrivi M, Bosi E, Burdet F, Fantuzzi F, De Luca C, Sebastiani G, Saponaro C, Pugliese LA, Del Guerra S, Pocai A, De Simone P, Ghinolfi D, Boggi U, Kessler C, Grieco GE, Fignani D, Kerr-Conte J, Pattou F, Nacher M, Montanya E, Mourad N, Buemi A, Citi V, Martelli A, Benedetti G, Calderone V, Rossi L, Paolicchi A, Cardarelli F, Dotta F, Eizirik DL, Ibberson M, Marchetti P, Cnop M, Marselli L
Trastuzumab deruxtecan in HER2-low metastatic breast cancer: long-term survival analysis of the randomized, phase 3 DESTINY-Breast04 trial.
AuteursModi S, Jacot W, Iwata H, Park YH, Vidal Losada M, Li W, Tsurutani J, Ueno NT, Zaman K, Prat A, Papazisis K, Rugo HS, Yamashita T, Harbeck N, Im SA, De Laurentiis M, Pierga JY, Wang X, Gombos A, Tokunaga E, Orbegoso Aguilar C, Yung L, Xiao F, Cheng Y, Cameron D